NCT02112799View on ClinicalTrials.gov

Safety and Efficacy Study of NVR 3-778 in Healthy Volunteers and Hepatitis B Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

May 18, 2016

Study Completion Date

May 18, 2016

Conditions
Chronic Hepatitis B
Interventions
DRUG

NVR 3-778

DRUG

Placebo for NVR 3-778

Sugar pill manufactured to mimic the NVR 3-778 capsule

DRUG

Pegasys

Trial Locations (2)

Unknown

Hamilton

Auckland

Sponsors
All Listed Sponsors
lead

Novira Therapeutics, Inc.

INDUSTRY